Efficacy, Safety and Tolerability of Sofpironium Gel, 12.45% in Adolescents and Young Adults with Primary Axillary Hyperhidrosis: Subgroup Analysis from Two Pivotal Phase 3 Trials

Sofdra (sofpironium bromide) - Botanix Pharma

https://eposters.aad.org/abstracts/72079

Martina Cartwright PhD; John Browning MD; Adelaide Hebert MD; Ted Lain MD; Patricia Walker MD; PhD

Mar 3, 2026